Skip to main content
. Author manuscript; available in PMC: 2014 Jun 9.
Published in final edited form as: Nat Med. 2013 Nov 7;19(11):1389–1400. doi: 10.1038/nm.3388

Figure 1.

Figure 1

EGFR signaling pathways. Activation of EGFR leads to downstream signaling pathways that ultimately drive tumor proliferation or impair apoptosis. These pathways mediate resistance through crosstalk or inappropriate activation but also provide targets for drugs to overcome resistance. IGFR, insulin-like growth factor receptor; PLC, phospholipase C; GAS6, growth arrest-specific 6.